Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A

P Giangrande; T Andreeva; P Chowdary; S Ehrenforth; H Hanabusa; Frank Leebeek; SR Lentz; L Nemes; LH Poulsen; E Santagostino; CW You; WHO Clausen; PG Jonsson; J Oldenburg

doi:10.1160/th16-06-0444

Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A

P Giangrande, T Andreeva, P Chowdary, S Ehrenforth, H Hanabusa, Frank Leebeek, SR Lentz, L Nemes, LH Poulsen, E Santagostino, CW You, WHO Clausen, PG Jonsson, J Oldenburg

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

82 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	252-261
Number of pages	10
Journal	Thrombosis and Haemostasis
Volume	117
Issue number	2
DOIs	https://doi.org/10.1160/th16-06-0444
Publication status	Published - 2017

Access to Document

10.1160/th16-06-0444

http://hdl.handle.net/1765/95835

Cite this

Giangrande, P., Andreeva, T., Chowdary, P., Ehrenforth, S., Hanabusa, H., Leebeek, F., Lentz, SR., Nemes, L., Poulsen, LH., Santagostino, E., You, CW., Clausen, WHO., Jonsson, PG., & Oldenburg, J. (2017). Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A. Thrombosis and Haemostasis, 117(2), 252-261. https://doi.org/10.1160/th16-06-0444

@article{5f120d71685a44109b9859e6346a7976,

title = "Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A",

author = "P Giangrande and T Andreeva and P Chowdary and S Ehrenforth and H Hanabusa and Frank Leebeek and SR Lentz and L Nemes and LH Poulsen and E Santagostino and CW You and WHO Clausen and PG Jonsson and J Oldenburg",

year = "2017",

doi = "10.1160/th16-06-0444",

language = "Undefined/Unknown",

volume = "117",

pages = "252--261",

journal = "Thrombosis and Haemostasis",

issn = "0340-6245",

publisher = "Georg Thieme Verlag",

number = "2",

}

Giangrande, P, Andreeva, T, Chowdary, P, Ehrenforth, S, Hanabusa, H, Leebeek, F, Lentz, SR, Nemes, L, Poulsen, LH, Santagostino, E, You, CW, Clausen, WHO, Jonsson, PG & Oldenburg, J 2017, 'Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A', Thrombosis and Haemostasis, vol. 117, no. 2, pp. 252-261. https://doi.org/10.1160/th16-06-0444

TY - JOUR

T1 - Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A

AU - Giangrande, P

AU - Andreeva, T

AU - Chowdary, P

AU - Ehrenforth, S

AU - Hanabusa, H

AU - Leebeek, Frank

AU - Lentz, SR

AU - Nemes, L

AU - Poulsen, LH

AU - Santagostino, E

AU - You, CW

AU - Clausen, WHO

AU - Jonsson, PG

AU - Oldenburg, J

PY - 2017

Y1 - 2017

U2 - 10.1160/th16-06-0444

DO - 10.1160/th16-06-0444

M3 - Article

SN - 0340-6245

VL - 117

SP - 252

EP - 261

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

IS - 2

ER -